Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-04-08

Clinical Trial Update: Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Danshen Dropping Pill for coronary artery disease and essential hypertension, focusing on heart and artery structure and funct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Danshen Dropping Pill

Snippet

Sponsor: West China Hospital | Conditions: Coronary Heart Disease, Essential Hypertension | Phase 4 | Status: UNKNOWN